Post by Octant

Octant is heading to ARVO 2026 in Denver! We have a full week of presentations and events this year spanning our RHO-adRP program – from genetics-based clinical trial design to AI-driven histopathology to small molecule corrector development. Here's where to find us: May 1 | 1:30–3:00 PM | Room 405, Level 3 | Eyecelerator Matthew Albert, MD, PhD | Session: Next Generation Retina Therapeutics & Advances in AI May 4 | 4:30–4:45 PM | Room 401 Connor Ludwig | "A bench-to-clinic framework for genetics-based trial enrollment in RHO-associated retinitis pigmentosa" May 5 | 10:30 AM–12:00 PM | Tamayo by Chef Richard Sandoval Fortrea + Octant Lunch & Learn / Mixer (lunch provided) May 5 | 3:30–5:15 PM | Poster Hall Leon Chan | "AI-Driven Histopathology Modeling Reveals Distinct PK/PD Drivers of Structural and Cellular Rescue in a RhoP23H/+ mouse model of adRP" May 7 | 11:45 AM–1:30 PM | Poster Hall Suzette Farber-Katz Brown | "Development of small molecule orthosteric correctors for the treatment of patients with rhodopsin-associated autosomal dominant retinitis pigmentosa (RHO-adRP)" If you're attending and want to connect, reach out – we'd love to meet up.